Cargando…
A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981624/ http://dx.doi.org/10.1186/1745-6215-14-S1-P21 |
| _version_ | 1782311075177299968 |
|---|---|
| author | Maycock, Nicola Dutton, Susan Sharma, Ricky |
| author_facet | Maycock, Nicola Dutton, Susan Sharma, Ricky |
| author_sort | Maycock, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3981624 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39816242014-04-24 A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) Maycock, Nicola Dutton, Susan Sharma, Ricky Trials Poster Presentation BioMed Central 2013-11-29 /pmc/articles/PMC3981624/ http://dx.doi.org/10.1186/1745-6215-14-S1-P21 Text en Copyright © 2013 Maycock et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Maycock, Nicola Dutton, Susan Sharma, Ricky A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) |
| title | A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) |
| title_full | A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) |
| title_fullStr | A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) |
| title_full_unstemmed | A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) |
| title_short | A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC) |
| title_sort | multi-centre randomised phase iii trial of radioembolisation (re) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (crc) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981624/ http://dx.doi.org/10.1186/1745-6215-14-S1-P21 |
| work_keys_str_mv | AT maycocknicola amulticentrerandomisedphaseiiitrialofradioembolisationrecombinedwithoxmdgcomparedwithoxmdgaloneasfirstlinetherapyforunresectableliveronlyorliverdominantmetastaticcolorectalcancercrc AT duttonsusan amulticentrerandomisedphaseiiitrialofradioembolisationrecombinedwithoxmdgcomparedwithoxmdgaloneasfirstlinetherapyforunresectableliveronlyorliverdominantmetastaticcolorectalcancercrc AT sharmaricky amulticentrerandomisedphaseiiitrialofradioembolisationrecombinedwithoxmdgcomparedwithoxmdgaloneasfirstlinetherapyforunresectableliveronlyorliverdominantmetastaticcolorectalcancercrc AT maycocknicola multicentrerandomisedphaseiiitrialofradioembolisationrecombinedwithoxmdgcomparedwithoxmdgaloneasfirstlinetherapyforunresectableliveronlyorliverdominantmetastaticcolorectalcancercrc AT duttonsusan multicentrerandomisedphaseiiitrialofradioembolisationrecombinedwithoxmdgcomparedwithoxmdgaloneasfirstlinetherapyforunresectableliveronlyorliverdominantmetastaticcolorectalcancercrc AT sharmaricky multicentrerandomisedphaseiiitrialofradioembolisationrecombinedwithoxmdgcomparedwithoxmdgaloneasfirstlinetherapyforunresectableliveronlyorliverdominantmetastaticcolorectalcancercrc |